Sanofi Partners with Abu Dhabi to Establish Vaccine Innovation Centre and Enhance Global Health

On June 23, 2026, Sanofi (SNY) and the Department of Health – Abu Dhabi (DoH) formalize their partnership to drive vaccine innovation through the signing of a Memorandum of Understanding. This collaboration focuses on establishing a Vaccine Innovation Centre in Abu Dhabi, where new capabilities in AI-driven vaccine discovery, mRNA research, clinical development, and manufacturing will take center stage. The aim is to bolster both regional and global preparedness for future public health challenges, reflecting a commitment to advancing health solutions in a rapidly evolving world. The MoU signing occurs during the BIO International Convention 2026 in San Diego, gathering key stakeholders to underscore the importance of this initiative.

Revolutionizing Vaccine Development

The partnership aligns with Abu Dhabi's Health, Endurance, Longevity, and Medicine (HELM) Cluster, creating a synergistic environment that integrates scientific research, clinical expertise, and innovative manufacturing. H.E. Dr. Noura Al Ghaithi, Undersecretary of DoH, emphasizes the role of this collaboration in significantly enhancing regional and global health infrastructures. The strategic combination of advanced production methods and regulatory support is poised to foster breakthroughs in vaccine development, thereby improving healthcare outcomes for communities worldwide.

Harnessing AI and mRNA Technology

Baptiste de Clarens, General Manager for Vaccines in Greater Gulf at Sanofi, expresses enthusiasm about leveraging artificial intelligence and mRNA technology to revolutionize vaccine innovation. This partnership represents a forward-thinking approach to connecting discovery, development, and manufacturing processes, potentially accelerating the route from scientific advances to tangible health solutions. As global health needs evolve, this initiative stands out as a significant step in expanding Abu Dhabi's role as a hub for health-related innovations, targeting improved health outcomes for patients across various communities.

Sanofi's Commitment to Global Health

Sanofi's commitment to vaccine innovation through this partnership underscores its broader mission to enhance public health worldwide by harnessing cutting-edge technologies and research capabilities.